Clinical trial
Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome…
NCT00417794 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00417794 |
|---|---|
| Title | Assess the Effectiveness of Atomoxetine in Children With Fetal Alcohol Syndrome and ADD/ADHD |
| Official title | A Study of the Efficacy of Atomoxetine in Treating the Inattention, Impulsivity and Hyperactivity in Children With Fetal Alcohol Syndrome or Effects |
| Acronym | B4Z-MC-X017 |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Mark L. Wolraich, M.D. Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Fetal Alcohol Syndrome, Attention Deficit Disorder With Hyperactivity (ADHD), Attention Deficit Disorder (ADD) |
| Intervention type | Drug |
| Interventions | Strattera, Placebo |
| Enrollment | 38 |
| Start date | Aug 1, 2005 |
| Primary completion | Apr 22, 2015 |
| Completion | Apr 22, 2015 |
| First posted | Jan 4, 2007 |
| Last update posted | Apr 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: